Internal Medicine, Gastroenterology · Williamsville, NY
NPI
1548246788
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
60 Maple Rd, Ste 1
Williamsville, NY, 14221
Phone (716) 626-5250
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
315 services
Medicare patients, 2024
209
Average age 73
Drug cost, 2024
$745K
2,206 prescriptions
Company payments, 2025
$640
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher J Bartolone was code 45385 (colonoscopy - lesion removal), 70 times for 70 patients. In total Christopher J Bartolone billed 315 services in 19 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-12-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Facility | 70 | 70 | $192.31 | $13K |
| 99214 Office E&M - Established | Office | 52 | 43 | $84.87 | $4,413 |
| 43239 Upper GI Endoscopy | Facility | 40 | 39 | $72.91 | $2,916 |
| 99204 Office E&M - New | Office | 31 | 31 | $99.35 | $3,080 |
| 99213 Office E&M - Established | Office | 26 | 25 | $63.45 | $1,650 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 19 | 19 | $2.70 | $51.34 |
| 45380 Lower GI Endoscopy - Other | Facility | 18 | 18 | $113.48 | $2,043 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 17 | 17 | $170.68 | $2,902 |
By year: 2022 $42K for 335 services; 2023 $35K for 298 services; 2024 $35K for 315 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher J Bartolone prescribed most often to Medicare patients was Omeprazole, with 351 prescriptions and refills. In total Christopher J Bartolone wrote 2,206 Medicare prescriptions that cost $745K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 351 | 923 | 115 | $5,757 |
| Famotidine Generic | 251 | 605 | 80 | $3,987 |
| Pantoprazole Sodium Generic | 232 | 677 | 83 | $4,925 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 125 | 125 | 122 | $2,476 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 107 | 107 | 106 | $18K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 98 | 98 | 98 | $1,951 |
| Colestipol Hcl Generic | 64 | 85 | 14 | $2,559 |
| Esomeprazole Magnesium Generic | 62 | 114 | 16 | $2,172 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 59 | 59 | 59 | $3,881 |
| Dicyclomine Hcl Generic | 51 | 54 | 16 | $745 |
| Linzess Linaclotide | 51 | 73 | 18 | $38K |
| Ursodiol Generic | 49 | 71 | Under 11 | $8,052 |
| Dexlansoprazole Dr Dexlansoprazole | 46 | 70 | Under 11 | $13K |
| Mesalamine Er Mesalamine | 44 | 78 | Under 11 | $24K |
| Azathioprine Generic | 42 | 96 | Under 11 | $2,764 |
Brand drugs: 454 claims; generic drugs: 1,752 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher J Bartolone $640 ($640 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $292.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 15 | $292 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 6 | $104 |
| Lilly USA, LLC LLY | 3 | $46.4 |
| Janssen Biotech, Inc. JNJ | 2 | $42.28 |
| Exact Sciences Corporation EXAS | 2 | $40.8 |
| QOL Medical, LLC | 1 | $31.85 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $24.6 |
| Madrigal Pharmaceuticals MDGL | 1 | $19.94 |
| Gilead Sciences, Inc. GILD | 1 | $19.53 |
| Aimmune Therapeutics, Inc. | 1 | $18.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.